Sang Jae Rhee Selected Research

Sang Jae Rhee Research Topics

Disease

13	Acute Coronary Syndrome 01/2021 - 05/2009
9	Myocardial Infarction 01/2023 - 11/2009
5	Cardiovascular Diseases (Cardiovascular Disease) 03/2014 - 05/2009
4	Thrombosis (Thrombus) 01/2020 - 03/2008
3	Stroke (Strokes) 01/2023 - 01/2011
3	Hemorrhage 01/2023 - 01/2020
2	Hypertension (High Blood Pressure) 09/2021 - 10/2006
2	Ischemia 01/2021 - 01/2011
2	Body Weight (Weight, Body) 01/2021 - 01/2021
2	Infarction (Infarctions) 09/2017 - 03/2014
2	ST Elevation Myocardial Infarction 09/2017 - 03/2014
2	Coronary Artery Disease (Coronary Atherosclerosis) 05/2017 - 10/2007
2	Myocardial Ischemia (Ischemic Heart Diseases) 05/2016 - 02/2008
2	Death (Near-Death Experience) 03/2013 - 01/2011
2	Atrial Fibrillation 12/2009 - 11/2009
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 09/2021
1	Dyslipidemias (Dyslipidemia) 09/2021
1	Venous Thromboembolism 07/2021
1	Anemia 01/2021
1	Heart Arrest (Cardiac Arrest) 01/2021
1	Chronic Renal Insufficiency 01/2021
1	Ischemic Stroke 01/2020
1	Transient Ischemic Attack 01/2020
1	Diabetes Mellitus 01/2020
1	Familial Primary Pulmonary Hypertension 01/2020
1	Stable Angina 03/2014
1	Pain (Aches) 03/2014
1	Wounds and Injuries (Trauma) 05/2012
1	Endoleak 05/2012
1	Aortic Diseases 05/2012
1	Chest Pain (Chest Pains) 01/2011
1	Mitral Valve Insufficiency (Mitral Regurgitation) 12/2009
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 06/2009
1	Heart Failure 02/2008
1	Coronary Stenosis (Coronary Artery Stenosis) 10/2007
1	Spasm (Spasms) 06/2006

Drug/Important Bio-Agent (IBA)

7	omega-Chloroacetophenone (Mace)IBA 01/2023 - 05/2009
6	Rosuvastatin Calcium (Crestor)FDA Link 05/2016 - 11/2009
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2014 - 11/2009
4	TicagrelorIBA 01/2023 - 09/2017
4	Clopidogrel (Plavix)FDA Link 09/2017 - 03/2008
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 01/2010
3	C-Reactive ProteinIBA 09/2014 - 10/2007
2	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2023 - 01/2020
2	Sirolimus (Rapamycin)FDA Link 01/2021 - 01/2020
2	HDL CholesterolIBA 05/2016 - 01/2011
2	Ergonovine (Ergometrine)IBA 01/2011 - 06/2006
2	oxidized low density lipoproteinIBA 01/2011 - 12/2009
2	CholesterolIBA 01/2011 - 10/2006
2	LDL CholesterolIBA 01/2011 - 12/2009
2	Triglycerides (Triacylglycerol)IBA 01/2011 - 12/2009
2	GadoliniumIBA 12/2009 - 06/2009
1	Antihypertensive Agents (Antihypertensives)IBA 09/2021
1	AnticoagulantsIBA 07/2021
1	Hemoglobins (Hemoglobin)IBA 01/2021
1	Epinephrine (Adrenaline)FDA LinkGeneric 01/2021
1	Potassium Chloride FDA LinkGeneric 01/2021
1	AntioxidantsIBA 01/2021
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 09/2017
1	Technetium (Technetium 99m)IBA 03/2014
1	HDL LipoproteinsIBA 11/2012
1	Nitroglycerin (Dynamite)FDA LinkGeneric 01/2011
1	Phenobarbital (Luminal)FDA Link 01/2011
1	pro-brain natriuretic peptide (1-76)IBA 02/2008
1	LipidsIBA 10/2007
1	CreatinineIBA 10/2007
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 10/2007
1	Thyroxine (Levothyroxine)FDA LinkGeneric 10/2007

Therapy/Procedure

12	Percutaneous Coronary Intervention 01/2020 - 05/2009
6	Stents 01/2021 - 03/2008
5	Therapeutics 01/2023 - 03/2008
1	Catheters 01/2021
1	Aftercare (After-Treatment) 05/2017
1	Endovascular Aneurysm Repair 05/2012
1	Length of Stay 05/2012
1	Catheter Ablation 11/2009
1	Drug-Eluting Stents 03/2008
1	Perioperative Period 03/2008